当前位置: X-MOL 学术AIDS Rev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cellular and Immune Therapy for Treating HIV-1 Infection.
AIDS Reviews ( IF 2.2 ) Pub Date : 2021-02-24 , DOI: 10.24875/aidsrev.20000110
Wei Li 1 , Qiqiang Zhou 1 , Lingbo Xia 1 , Ruixiang Zou 1 , Wei Zou 2
Affiliation  

HIV-1 infection has caused a number of deaths worldwide and remains a global health concern. Combined antiretroviral therapy (cART) inhibits viral replication, prevents CD4+ T cell loss, and thus slows HIV disease progression. However, cART does not eradicate HIV-1. Infected individuals must remain on treatment for their entire lives and treatment interruption will result in viral rebound.

中文翻译:

用于治疗 HIV-1 感染的细胞和免疫疗法。

HIV-1 感染已在世界范围内造成许多人死亡,并且仍然是一个全球性的健康问题。联合抗逆转录病毒疗法 (cART) 可抑制病毒复制,防止 CD4+ T 细胞丢失,从而减缓 HIV 疾病进展。但是,cART 并不能根除 HIV-1。感染者必须终生接受治疗,治疗中断将导致病毒反弹。
更新日期:2021-02-26
down
wechat
bug